Meningococcal vaccines: Present status and perspectives;Vaccins contre le méningocoque: Actualités et perspectives

Therapie

Volumn 60, Issue 3, 2005, Pages 283-286

  Alonso, Jean Michel ^a   Taha, Muhamed Kheir ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Neisseria meningitidis; Polysaccharides; Serogroups; Specificity; Vaccines

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; MEMBRANE PROTEIN; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

BACTERIAL ARTHRITIS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BLOOD GROUP TYPING; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFICACY; DRUG SCREENING; HUMAN; IMMUNITY; INFECTION PREVENTION; MENINGITIS; MENINGOCOCCOSIS; MOLECULAR CLOCK; NEISSERIA MENINGITIDIS; PERICARDITIS; PRIORITY JOURNAL; SEPTICEMIA; SYMPTOM; VACCINATION; IMMUNOLOGY; MICROBIOLOGY; REVIEW;

HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES;

EID: 24944493285     PISSN: 00405957     EISSN: 00405957     Source Type: Journal    
DOI: 10.2515/therapie:2005037     Document Type: Conference Paper

References (15)

1. World Health Organization. Control of epidemic meningococcal disease. WHO practical guidelines. 2nd ed. Geneva: WHO, 1998
2. Van Deuren M, Brandzaeg P, van Der Meer JWM. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13: 144-66
3. Young LS, Laforce JJ, Head JC, et al. A simultaneous outbreak of meningococcal and influenza infections. N Engl J Med 1979; 287: 5-9
4. Arstenstein MS, Rust JH, Hunter DH, et al. Acute respiratory disease and meningococcal infection in army recruits. JAMA 1967; 201: 1004-8
5. Moore PS, Hierholzer J, Dewitt W, et al. Respiratory virus and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 1990; 264: 1271-5
6. Cartwright KAV, Jones DM, Smith AJ, et al. Influenza A virus and meningococcal disease. Lancet 1991; 338: 554-7
7. Hubert B, Watier L, Garnerin P, et al. Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis 1992; 166: 542-5
8. Caugant D. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998; 106: 505-25
9. Taha MK, Achtman M, Alonso JM, et al. Serogroup W135 meningococcal disease in Hajj pilgrims [letter]. Lancet 2000; 356: 2159
10. Matsika-Claquin MD, Perrocheau A, Taha MK, et al. Epidémie d'infections à méningocoque W135 liée au pèlerinage de la Mecque de 2000. Presse Med 2001; 30: 1529-34
11. Bowler LD, Zhang QY, Riou JY, et al. Inter-species recombination between the penA genes of Neisseria meningitidis and commensal Neisseria during the emergence of penicillin resistance in N. meningitidis: natural events and laboratory simulation. J Bacteriol 1994; 176: 333-7
12. Maiden MCJ. Population genetics of a transformable bacterium: the influence of horizontal genetic exchange on the biology of Neisseria meningitidis. FEMS Microbiol Lett 1993; 112: 243-50
13. Perez-Trallero E, Vicente D, Montes M, et al. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis [letter]. Lancet 2002; 360: 953
14. Kriz P, Giorgini D, Musilek M, et al. Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic. Res Microbiol 1999; 150: 273-80
15. Kertesz DA, Coulthart MB, Ryan JA, et al. Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada. J Infect Dis 1998; 177: 1754-7